TcrossGlobal

Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland

The long-term follow-up of the SCOT-HEART trial demonstrated that in patients with stable chest pain, coronary CT angiography (CCTA)-guided management reduced the 10-year risk of coronary heart disease death or non-fatal myocardial infarction (MI) compared to standard care alone, Dr. Michelle C Williams and colleagues, University of Edinburgh, UK, reported in the January 25 issue of The Lancet.

The SCOT-HEART trial enrolled 4,146 patients aged 18-75 years with suspected stable angina due to co...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.

Recommendations

Complete vs Culprit-Lesion-Only Revascularization for AMI: A Patient-Level Meta-Analysis of Randomized Trials

Lancet

$Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial$

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

Lancet

$Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: The FLAVOUR II Trial$